📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Avadel Pharmaceuticals

1.1 - Company Overview

Avadel Pharmaceuticals Logo

Avadel Pharmaceuticals

Headquarter: Ireland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical products developed via proprietary drug delivery technology and in-licensing/acquisitions to create safe, effective, easy-to-take formulations; offers LUMRYZ, a central nervous system depressant for treating cataplexy or excessive daytime sleepiness in adults with narcolepsy, available through a restricted program.

Products and services

  • LUMRYZ: A program-restricted central nervous system depressant addressing cataplexy and excessive daytime sleepiness in adults with narcolepsy, distributed exclusively via a restricted program to ensure controlled use
  • Proprietary Drug Delivery Technology: A proprietary platform utilized to engineer differentiated pharmaceuticals that are safe, effective, and easy to take via formulation development
  • Formulation Development: A formulation-based capability to develop differentiated pharmaceutical products that are safe, effective, and easy to take

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Avadel Pharmaceuticals

Pixelligent Logo

Pixelligent

HQ: United States Website
  • Description: Provider of synthetic metal oxide nanocrystal materials and a proprietary development and manufacturing platform. PixClearProcess controls nanocrystal size, uniformity, and dispersibility. Offerings include PixClear titania and zirconia compounds for next-gen displays, XR, sensors, and optics; PixNIL high-index nanoimprint formulations; PixJet inkjettable formulations for electronic displays; and PixCor UV/titania stability formulations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pixelligent company profile →
Vorbeck Materials Logo

Vorbeck Materials

HQ: United States Website
  • Description: Provider of graphene materials (Vor-x) for industrial and energy applications; ultra-flexible, robust conductive inks and coatings (Vor-ink) for printed electronics; high-performance graphene-enabled electronic components; and custom technology solutions for municipalities, states, US Special Operations Command, and front-line troops, focusing on high-bandwidth communication and situational awareness.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vorbeck Materials company profile →
Fogale Nanotech Logo

Fogale Nanotech

HQ: France Website
  • Description: Provider of inspection and metrology tools, and process control and characterization solutions for MEMS and semiconductor manufacturers and labs. Offerings include sensing solutions for advanced performance and reliability in harsh environments, medical human-machine interaction systems focusing on ergonomics and surgical room safety, metrological instrumentation for industrial, scientific research, nuclear and defense markets, and blade health monitoring systems.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fogale Nanotech company profile →
BeDimensional Logo

BeDimensional

HQ: Italy Website
  • Description: Provider of graphene and other two-dimensional materials with few atomic layers. Offers graphene-based solutions for lithium-ion batteries to improve performance and longevity; graphene-based lubricants to reduce friction and energy consumption; and B-Leaf h-BN coatings, including concentrates for aqueous, high/medium, and medium polarity systems, plus an h-BN-based anticorrosion paint.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BeDimensional company profile →
NDP Diamonds Logo

NDP Diamonds

HQ: Ireland Website
  • Description: Provider of superhard products, developing a portfolio of diamond and cubic boron nitride (cBN) materials, including CVD diamond, spanning sizes from nanometres to millimetres for a wide range of industries; since January 2021, a wholly owned subsidiary of Hyperion Materials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NDP Diamonds company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Avadel Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Avadel Pharmaceuticals

2.2 - Growth funds investing in similar companies to Avadel Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Avadel Pharmaceuticals

4.2 - Public trading comparable groups for Avadel Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Avadel Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Avadel Pharmaceuticals

What does Avadel Pharmaceuticals do?

Avadel Pharmaceuticals is a provider of specialty pharmaceutical products developed via proprietary drug delivery technology and in-licensing/acquisitions to create safe, effective, easy-to-take formulations; offers LUMRYZ, a central nervous system depressant for treating cataplexy or excessive daytime sleepiness in adults with narcolepsy, available through a restricted program.

Who are Avadel Pharmaceuticals's competitors?

Avadel Pharmaceuticals's competitors and similar companies include Pixelligent, Vorbeck Materials, Fogale Nanotech, BeDimensional, and NDP Diamonds.

Where is Avadel Pharmaceuticals headquartered?

Avadel Pharmaceuticals is headquartered in Ireland.

How many employees does Avadel Pharmaceuticals have?

Avadel Pharmaceuticals has 1,000 employees 🔒.

When was Avadel Pharmaceuticals founded?

Avadel Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Avadel Pharmaceuticals in?

Avadel Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Avadel Pharmaceuticals

Who are the top strategic acquirers in Avadel Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Avadel Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Avadel Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Avadel Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Avadel Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Avadel Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Avadel Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Avadel Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Avadel Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Avadel Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Avadel Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Avadel Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Avadel Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Avadel Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Avadel Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Avadel Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Avadel Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Avadel Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Avadel Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Avadel Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Avadel Pharmaceuticals

Launch login modal Launch register modal